Chemotherapy's traditional approach often lacks precision, targeting both cancerous and healthy cells indiscriminately. New technologies, such as blood biopsies, can provide insights into how to tailor treatments to individual patients, yet many institutions still adhere to outdated methods. The conversation highlights the need for a shift towards adaptive strategies that harness the body's immune response and consider the evolving nature of tumors.
